Chemical Research in Toxicology · 2001 · 58 citations · 33 references
Life SciencesPharmacologyToxicologyEnzymologyMetabolismMolecular PharmacologyEnzyme InhibitionMolecular Mechanisms Of ToxicityXenobiotic MetabolismEpoxide Hydrolase ActivityEpoxide HydrolasesInhibition KineticsMicrosomal Enzyme ActivityMicrosomal Enzyme-mediated MetabolismNoncompetitive InhibitionSubstrate Inhibition KineticsToxicological Physiology
The microsomal epoxide hydrolase (mEH) plays a significant role in the metabolism of xenobiotics such as polyaromatic toxicants. Additionally, polymorphism studies have underlined a potential role of this enzyme in relation to several diseases, such as emphysema, spontaneous abortion, and several forms of cancer. To provide new tools for studying the function of mEH, inhibition of this enzyme was investigated. Inhibition of recombinant rat and human mEH was achieved using primary ureas, amides, and amines. Several of these compounds are more potent than previously published inhibitors. Elaidamide, the most potent inhibitor that is obtained, has a K(i) of 70 nM for recombinant rat mEH. This compound interacts with the enzyme forming a noncovalent complex, and blocks substrate turnover through an apparent mix of competitive and noncompetitive inhibition kinetics. Furthermore, in insect cell cultures expressing rat mEH, elaidamide enhances the toxicity effects of epoxide-containing xenobiotics. These inhibitors could be valuable tools for investigating the physiological and toxicological roles of mEH.
33
Control of pain initiation by endogenous cannabinoids
Antonio Calignano, Giovanna La Rana, Andrea Giuffrida et al. · Nature · 1998 · 1.1K citations
Medicine, Neurobiology, Pharmacology +14
Chemical Characterization of a Family of Brain Lipids That Induce Sleep
Benjamin F. Cravatt, Oscar Prospéro‐García, Gary Siuzdak et al. · Science · 1995 · 619 citations
Choice Reviews Online · 1997 · 551 citations